Madrigal Pharma(MDGL.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Madrigal Pharma
MDGL.US
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
1.891 T
MDGL.USMarket value -Rank by Market Cap -/-

Financial Score

14/03/2026 Update
C
BiotechnologyIndustry
Industry Ranking71/402
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-42.49%E
    • Profit Margin-30.08%E
    • Gross Margin94.14%A
  • Growth ScoreA
    • Revenue YoY432.05%A
    • Net Profit YoY38.12%B
    • Total Assets YoY20.85%A
    • Net Assets YoY-20.11%E
  • Cash ScoreB
    • Cash Flow Margin-332.45%D
    • OCF YoY432.05%A
  • Operating ScoreB
    • Turnover0.83B
  • Debt ScoreC
    • Gearing Ratio52.15%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

    Unusual Whales·
    US
    BBH
    -0.23%
    US
    FBT
    -0.49%
    US
    BIB
    -0.99%
    Unusual Whales·
    US
    BBH
    -0.23%
    US
    FBT
    -0.49%
    US
    BIB
    -0.99%

    MADRIGAL PHARMACEUTICALS EVP and CFO Sells Shares to Cover Tax Obligations

    TradingView·
    US
    FBT
    -0.49%
    US
    ARKG
    +0.73%
    US
    PBE
    0.00%
    TradingView·
    US
    FBT
    -0.49%
    US
    ARKG
    +0.73%
    US
    PBE
    0.00%

    Sagimet Biosciences Highlights Denifanstat MASH Data, Combo Plans at Oppenheimer Healthcare Conf.

    Market Beat·
    US
    XBI
    -0.64%
    US
    FBT
    -0.49%
    US
    ARKG
    +0.73%
    Market Beat·
    US
    XBI
    -0.64%
    US
    FBT
    -0.49%
    US
    ARKG
    +0.73%

    Barclays Remains a Buy on Madrigal Pharmaceuticals (MDGL)

    Tip Ranks·
    US
    IBB
    -0.43%
    US
    XBI
    -0.64%
    US
    IHE
    -0.12%
    Tip Ranks·
    US
    IBB
    -0.43%
    US
    XBI
    -0.64%
    US
    IHE
    -0.12%

    Madrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

    benzinga_article·
    US
    ARKG
    +0.73%
    US
    VHT
    -0.19%
    US
    FBT
    -0.49%
    benzinga_article·
    US
    ARKG
    +0.73%
    US
    VHT
    -0.19%
    US
    FBT
    -0.49%
    © 2026 Longbridge｜Disclaimer